Source: Annual Congress 2011 - Asthma: basic science and clinical studies
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Gagliardo, S. La Grutta, P. Chanez, A. Sala, L. Siena, C. Di Sano, L. Riccobono, G. Viegi, M. Gjomarkaj, M. Profita (Palermo, Milano, Italy; Marseille, France). The interplay of LXA4 and glucocorticoid receptor-based mechanisms in airway inflammation of childhood asthma. Eur Respir J 2011; 38: Suppl. 55, 3267

Member's Comments

No comment yet.

Related content which might interest you: A fully dissociated glucocorticoid receptor modulator reduces airway hyperresponsiveness and inflammation in a murine model of asthma Source: Annual Congress 2010 - Pre-clinical models of airways disease Year: 2010 Role of IL-33 signaling in pollutant-induced allergic airway inflammation Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases Year: 2018 Molecular-cellular mechanisms of combined airway hyperresponsiveness in asthma Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017 IL-33 blockade impacts mediators of persistence and exacerbation of chronic airway inflammation. Source: International Congress 2018 – Novel drug targets for asthma and COPD Year: 2018 Benralizumab attenuates airway eosinophilopoietic processes in prednisone-dependent asthma Source: International Congress 2017 – Monitoring novel biomarkers in asthma Year: 2017 Estrogen prevents airway inflammation and hyperresponsiveness in a murine model of acute allergic asthma Source: Eur Respir J 2007; 30: Suppl. 51, 360s Year: 2007 A dual role of IL-6 signalling and STAT-3 activation on airway inflammation versus airway hyperresponsiveness in a murine model of asthma Source: Eur Respir J 2002; 20: Suppl. 38, 568s Year: 2002 The association between obesity and asthma: interactions between systemic and airway inflammation Source: Annual Congress 2008 - Understanding airway inflammation Year: 2008 Novel concepts in airway inflammation and remodelling in asthma Source: Eur Respir J 2015; 46: 1796-1804 Year: 2015 The potential mechanism of Th17/Treg imbalance in the microenvironments of chronic inflammation and allergic asthma Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma Year: 2012 The inflammation and the airway hyperresponsiveness in allergic asthma is inhibited by IL-10 dependent mechanism Source: Annual Congress 2007 - Mouse models of allergic airway inflammation Year: 2007 Comparison of glucocorticoid and cysteinyl leukotriene receptor antagonist treatments in the airway remodeling induced by chronic airway inflammation in guinea pigs Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II Year: 2008 IL-33 blockade prevents exacerbations in a model of chronic airway inflammation by blunting persistent inflammation and remodeling Source: International Congress 2019 – Advances in asthma pharmacology Year: 2019 Estrogen prevents airway hyperresponsiveness in a murine model of allergic asthma Source: Eur Respir J 2006; 28: Suppl. 50, 433s Year: 2006 Understanding the mechanisms of LASSBio596 on airway remodeling in asthma Source: Annual Congress 2007 - Recent advances in our understanding of the mechanisms of asthma treatment Year: 2007 Corticosteroid effects on airway neuroplasticity in experimental models of asthma Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021 The effects of capsaicin on airway inflammation in asthma patients Source: Eur Respir J 2004; 24: Suppl. 48, 586s Year: 2004 The mechanisms of glucocorticoid (GC)-induced lymphocyte apoptosis in atopic bronchial asthma (ABA) Source: Eur Respir J 2002; 20: Suppl. 38, 29s Year: 2002 A potential role of P2X7R in allergic airway inflammation Source: Annual Congress 2010 - Asthma: basic science and clinical studies Year: 2010 Photobiomodulation and corticosteroid modulate pulmonary inflammation and airway reactivity in an experimental model of chronic asthma Source: International Congress 2018 – Basic pharmacology Year: 2018